Orphan drugs improve health — but aren't priced cost-effectively

Orphan drugs improve health — but aren't priced cost-effectively

STAT Plus: Orphan drugs improve health — but aren’t priced cost-effectively, study finds

By ED SILVERMAN

APSTOCK

A new study finds that orphan drugs are likely to improve heath, but often aren't priced in a way that makes them cost-effective.

READ MORE